| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008492484 |
| P356 | DOI | 10.1007/S11883-012-0243-2 |
| P698 | PubMed publication ID | 22528520 |
| P5875 | ResearchGate publication ID | 224824605 |
| P50 | author | Robert A. Hegele | Q58046422 |
| P2093 | author name string | Christopher T Johansen | |
| P2860 | cites work | Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects | Q24298184 |
| Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase | Q24323221 | ||
| Biological, clinical and population relevance of 95 loci for blood lipids | Q24622541 | ||
| Hypertriglyceridemia: its etiology, effects and treatment | Q24672914 | ||
| Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia | Q28118749 | ||
| Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies | Q28281855 | ||
| Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia | Q28295479 | ||
| Genetic and developmental regulation of the lipoprotein lipase gene: loci both distal and proximal to the lipoprotein lipase structural gene control enzyme expression | Q28593108 | ||
| Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia | Q28943439 | ||
| Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia | Q33644452 | ||
| Quantitative trait locus mapping and identification of Zhx2 as a novel regulator of plasma lipid metabolism. | Q33758277 | ||
| Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment | Q34048473 | ||
| Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia | Q34089350 | ||
| Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation | Q34164025 | ||
| Genetic determinants of plasma triglycerides | Q34503333 | ||
| Triglycerides and heart disease: still a hypothesis? | Q35120360 | ||
| The role of triglycerides in atherosclerosis | Q35602424 | ||
| Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia | Q35784042 | ||
| New wrinkles in lipoprotein lipase biology. | Q36060371 | ||
| Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). | Q36087336 | ||
| An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia | Q36582772 | ||
| Common and rare gene variants affecting plasma LDL cholesterol | Q36711327 | ||
| Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. | Q37036119 | ||
| A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection | Q37171168 | ||
| Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. | Q37389540 | ||
| Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk | Q37848012 | ||
| Genetic bases of hypertriglyceridemic phenotypes | Q37868881 | ||
| Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia | Q39369438 | ||
| Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3. | Q39446839 | ||
| Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women | Q40192779 | ||
| The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism | Q41909224 | ||
| Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. | Q43106855 | ||
| A specific apoprotein activator for lipoprotein lipase | Q44766585 | ||
| Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene | Q46715156 | ||
| Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women | Q61162458 | ||
| Apolipoprotein A5 and hypertriglyceridemia | Q81341210 | ||
| P433 | issue | 3 | |
| P921 | main subject | triglyceride | Q186319 |
| P304 | page(s) | 227-234 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | The complex genetic basis of plasma triglycerides | |
| P478 | volume | 14 |
| Q61804191 | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
| Q64121082 | Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups |
| Q36197671 | Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia |
| Q38366873 | Chylomicronaemia--current diagnosis and future therapies |
| Q34689708 | Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks |
| Q38141575 | Demystifying the management of hypertriglyceridaemia. |
| Q46588659 | Genetic risk prediction in a small cohort of healthy adults in Atlanta |
| Q39324048 | Genetics of Triglycerides and the Risk of Atherosclerosis |
| Q60533968 | Hypertriglyceridemia |
| Q94365453 | Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia |
| Q38076370 | Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies. |
| Q36744086 | Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. |
Search more.